NOVAREX Co.Ltd Net Assets
NOVAREX Co.Ltd net assets. Based on the latest financial reports, NOVAREX Co.Ltd (194700) has net assets worth ₩260.64 Billion KRW (≈ $176.63 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩373.19 Billion ≈ $252.91 Million USD) and total liabilities (₩112.55 Billion ≈ $76.27 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is NOVAREX Co.Ltd growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩260.64 Billion |
| % of Total Assets | 69.84% |
| Annual Growth Rate | 21.5% |
| 5-Year Change | 82.32% |
| 10-Year Change | 470.72% |
| Growth Volatility | 11.72 |
Net Assets of NOVAREX Co.Ltd (2015–2025)
Net assets of NOVAREX Co.Ltd from 2015 to 2025. This chart illustrates how NOVAREX Co.Ltd's net assets have evolved over time, based on quarterly financial data. See NOVAREX Co.Ltd (194700) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for NOVAREX Co.Ltd (2015–2025)
The table below shows the annual net assets of NOVAREX Co.Ltd from 2015 to 2025. For live market cap and overall valuation, see NOVAREX Co.Ltd (194700) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩254.64 Billion ≈ $172.57 Million |
+15.61% |
| 2024-12-31 | ₩220.26 Billion ≈ $149.27 Million |
+9.90% |
| 2023-12-31 | ₩200.42 Billion ≈ $135.82 Million |
+10.50% |
| 2022-12-31 | ₩181.37 Billion ≈ $122.91 Million |
+29.86% |
| 2021-12-31 | ₩139.67 Billion ≈ $94.65 Million |
+20.81% |
| 2020-12-31 | ₩115.61 Billion ≈ $78.35 Million |
+25.95% |
| 2019-12-31 | ₩91.79 Billion ≈ $62.21 Million |
+16.30% |
| 2018-12-31 | ₩78.93 Billion ≈ $53.49 Million |
+52.14% |
| 2017-12-31 | ₩51.88 Billion ≈ $35.16 Million |
+16.27% |
| 2016-12-31 | ₩44.62 Billion ≈ $30.24 Million |
+22.89% |
| 2015-12-31 | ₩36.31 Billion ≈ $24.61 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to NOVAREX Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 960.5% over the analyzed period, indicating profitable operations and earnings retention.
NOVAREX Co.Ltd Net Assets Breakdown (December 2025)
NOVAREX Co.Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩216.62 Billion | 85.58% |
| Other Components | ₩36.50 Billion | 14.42% |
| Total Equity | ₩253.12 Billion | 100.00% |
NOVAREX Co.Ltd Competitors by Market Cap
The table below lists competitors of NOVAREX Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sunspring Metal Corp
TW:2062
|
$106.49 Million |
|
LINMON MEDIA LTD -000025
F:8MN
|
$106.53 Million |
|
American Resources Corp Class A
NASDAQ:AREC
|
$106.58 Million |
|
Tunghsu Azure Renewable Energy Co Ltd
SHE:000040
|
$106.61 Million |
|
Wonder Electricals Limited
NSE:WEL
|
$106.48 Million |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
$106.47 Million |
|
DAM CAPITAL ADVISORS LTD
NSE:DAMCAPITAL
|
$106.46 Million |
|
Goknur Gida Maddeleri Enerji Imalati Ithalat Ihracat Ticaret ve Sanayi A.S.
IS:GOKNR
|
$106.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NOVAREX Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 219,256,138,080 to 253,123,794,050, a change of 33,867,655,970 (15.4%).
- Net income of 35,416,064,440 contributed positively to equity growth.
- Dividend payments of 3,540,443,200 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩35.42 Billion | +13.99% |
| Dividends Paid | ₩3.54 Billion | -1.4% |
| Other Changes | ₩1.99 Billion | +0.79% |
| Total Change | ₩- | 15.45% |
Book Value vs Market Value Analysis
This analysis compares NOVAREX Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.62x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.08x to 0.62x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩2870.45 | ₩8850.00 | x |
| 2017-12-31 | ₩3331.82 | ₩8850.00 | x |
| 2018-12-31 | ₩4875.78 | ₩8850.00 | x |
| 2019-12-31 | ₩5670.58 | ₩8850.00 | x |
| 2020-12-31 | ₩7142.03 | ₩8850.00 | x |
| 2021-12-31 | ₩8628.31 | ₩8850.00 | x |
| 2022-12-31 | ₩10231.49 | ₩8850.00 | x |
| 2023-12-31 | ₩11311.17 | ₩8850.00 | x |
| 2024-12-31 | ₩12385.80 | ₩8850.00 | x |
| 2025-12-31 | ₩14298.99 | ₩8850.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NOVAREX Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.99%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.76%
- • Asset Turnover: 1.12x
- • Equity Multiplier: 1.42x
- Recent ROE (13.99%) is below the historical average (16.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 26.63% | 11.69% | 1.47x | 1.55x | ₩6.04 Billion |
| 2016 | 20.62% | 11.93% | 1.28x | 1.35x | ₩4.74 Billion |
| 2017 | 15.62% | 10.02% | 1.13x | 1.38x | ₩2.92 Billion |
| 2018 | 12.02% | 8.84% | 1.01x | 1.35x | ₩1.60 Billion |
| 2019 | 16.02% | 9.25% | 1.03x | 1.68x | ₩5.53 Billion |
| 2020 | 21.75% | 11.28% | 1.03x | 1.86x | ₩13.58 Billion |
| 2021 | 18.90% | 9.47% | 1.09x | 1.82x | ₩12.43 Billion |
| 2022 | 11.03% | 7.10% | 1.04x | 1.49x | ₩1.87 Billion |
| 2023 | 11.01% | 7.29% | 1.14x | 1.32x | ₩2.01 Billion |
| 2024 | 10.50% | 7.73% | 1.03x | 1.32x | ₩1.09 Billion |
| 2025 | 13.99% | 8.76% | 1.12x | 1.42x | ₩10.10 Billion |
Industry Comparison
This section compares NOVAREX Co.Ltd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $519,859,440,456
- Average return on equity (ROE) among peers: 4.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NOVAREX Co.Ltd (194700) | ₩260.64 Billion | 26.63% | 0.43x | $106.49 Million |
| Daehan Flour Mills Co Ltd (001130) | $558.82 Billion | 0.93% | 0.51x | $11.94 Million |
| Daesang Corp (001680) | $353.96 Billion | 0.00% | 2.25x | $401.28 Million |
| Daesang Corp Preference Shares (001685) | $1.02 Trillion | 10.49% | 1.35x | $12.83 Million |
| Korea Ind (002140) | $105.65 Billion | 0.65% | 1.60x | $29.51 Million |
| Choheung (002600) | $145.74 Billion | 11.03% | 0.84x | $56.88 Million |
| Sam Yang Foods (003230) | $395.69 Billion | 14.24% | 0.90x | $6.01 Billion |
| Daejoo Inc (003310) | $45.76 Billion | 2.57% | 0.78x | $34.54 Million |
| Harim Holdings Co. Ltd (003380) | $1.69 Trillion | 3.23% | 4.53x | $765.90 Million |
| Hansung Ent (003680) | $53.05 Billion | -0.09% | 3.35x | $12.75 Million |
| Namyang Dairy (003920) | $823.93 Billion | 0.02% | 0.17x | $166.49 Million |
About NOVAREX Co.Ltd
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more